Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes

计划入组 1,845 人 · 首次发布于 2018 年 3 月 15 日

Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome

计划入组 50 人 · 首次发布于 2020 年 5 月 29 日

Postoperative Pain and Angiotensin II Receptor Antagonists

计划入组 90 人 · 首次发布于 2015 年 8 月 3 日

Angiotensin II(Giapreza)

Angiotensin-II receptor antibody

Angiotensin 1-7

C₄₁H₆₂N₁₂O₁₁

Arvinas Estrogen Receptor, Inc.

United States

NHI-1

United States

Arvinas Androgen Receptor, Inc.

United States

Swissmedic Approves Filspari (sparsentan) for IgA Nephropathy

EMA Panel Recommends Sparsentan for IgA Nephropathy, Paving Way for EU Approval

Angiotensin II and Thromboembolism Risk Re-evaluated in Critical Care